Numinus Wellness (TSE:NUMI) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Numinus Wellness Inc. reported a slight decline in revenue and gross profit in Q3 of Fiscal 2024, alongside a modest cash position and an increased number of client appointments in the U.S. They have transitioned out of Canadian clinical operations to focus on U.S. clinics and late-stage drug trials. Additionally, Numinus is planning to acquire MedBright AI Investments Inc., extending its reach in mental health care through a stock-based transaction.
For further insights into TSE:NUMI stock, check out TipRanks’ Stock Analysis page.
